Arcutis Biotherapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ARQT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

231,734

Value ($000)

6,730

Weight

0.0%

2021 Q1 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	6,730	0.0%	231,734	12/31/2025
2025 Q3	11/14/2025	4,600	0.0%	244,015	9/30/2025
2025 Q2	8/14/2025	5,674	0.0%	404,736	6/30/2025
2025 Q1	5/19/2025	4,364	0.0%	279,047	3/31/2025
2024 Q4	2/14/2025	3,902	0.0%	280,100	12/31/2024
2024 Q3	11/14/2024	2,573	0.0%	276,691	9/30/2024
2024 Q2	8/14/2024	2,546	0.0%	273,779	6/30/2024
2023 Q3	11/13/2023	431	0.0%	81,080	9/30/2023
2023 Q2	8/11/2023	656	0.0%	59,615	6/30/2023
2023 Q1	5/15/2023	656	0.0%	59,615	3/31/2023
2022 Q4	2/14/2023	499	0.0%	33,716	12/31/2022
2022 Q3	11/14/2022	365	0.0%	19,100	9/30/2022
2022 Q2	8/12/2022	639	0.0%	29,972	6/30/2022
2022 Q1	5/16/2022	577	0.0%	29,972	3/31/2022
2021 Q4	2/14/2022	622	0.0%	29,972	12/31/2021
2021 Q3	11/15/2021	716	0.0%	29,972	9/30/2021
2021 Q2	8/16/2021	818	0.0%	29,972	6/30/2021
2021 Q1	5/14/2021	613	0.0%	21,200	3/31/2021